Glanzmann's thrombasthenia, also known as GT, is a rare inherited bleeding disorder characterized by the inability of platelets to properly clot blood. This condition is caused by mutations in the genes responsible for the glycoprotein IIb/IIIa complex, which is essential for platelet aggregation.
Individuals with Glanzmann's thrombasthenia may experience prolonged bleeding, easy bruising, and excessive bleeding following injuries or surgeries. The severity of symptoms can vary from mild to severe, depending on the specific genetic mutation and the level of functional glycoprotein IIb/IIIa complex.
Synonyms for Glanzmann's thrombasthenia include:
It is important for individuals with Glanzmann's thrombasthenia to receive appropriate medical care and management. Treatment options may include platelet transfusions, medications to promote platelet function, and preventive measures to minimize the risk of bleeding episodes.
Genetic counseling is also recommended for affected individuals and their families, as Glanzmann's thrombasthenia is an autosomal recessive disorder. This means that both parents must carry a copy of the mutated gene for their child to be affected.
Overall, Glanzmann's thrombasthenia is a rare bleeding disorder characterized by impaired platelet function. Understanding the synonyms associated with this condition can help individuals and healthcare professionals in their search for information and appropriate medical care.